Skip to Main Content
About this Publication
Title
Whole blood cryopreservation in epidemiological studies.
Pubmed ID
12433734 (View this publication on the PubMed website)
Publication
Cancer Epidemiol. Biomarkers Prev. 2002 Nov; Volume 11 (Issue 11): Pages 1496-8
Authors

Hayes RB, Smith CO, Huang WY, Read Y, Kopp WC

Abstract

Standardized and cost-effective biological sample collection, processing, and storage procedures are needed in large-scale epidemiological studies to provide material for testing a broad range of etiological hypotheses. One component of sample collection in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial involves shipment of blood in acid-citrate-dextrose anticoagulant to a central processing laboratory, where 10% DMSO is added, and whole blood aliquots are cryopreserved. A single technician is able to routinely process 50-60 samples/day. Tests conducted to evaluate potential uses of cryopreserved whole blood showed successful EBV transformation (>90%, up to 20 months of storage). In addition, lymphocytes maintained good viability and stable T-cell:B-cell ratios, and T cells maintained the capacity to proliferate in response to solid phase anti-CD3/CD28 plus interleukin 2. Whole blood cryopreservation is a cost-effective approach to large-scale storage of viable cells in epidemiological studies.

Related CDAS Studies